Evidence

Woulgan Bioactive Beta-Glucan Gel is documented through several published papers and case studies

Woulgan contains SBG as an ancillary medicinal ingredient. In addition to having typical gel qualities aiding in optimal moist conditions and autolytic debridement etc, the SBG ingredient increases angiogenesis, cell proliferation and wound contraction[1]. The positive effects of SBG in treatment of diabetic foot ulcers have been studied and showed a statistically significant positive effect of SBG in complete wound healing at week 8 compared to control[2].

You can access the above mentioned study, other publisher papers and our case studies on Woulgan from menu to the left.

References
  1. Skjæveland & Engstad 2013
  2. Zykova et al 2014

Explore further

  1. Management approaches to restart healing in stalled wounds

    At any point in the healing trajectory, a wound can become stalled. That is, the wound initially began to heal, but patient- or wound-related factors have prevented the wound from continuing to heal in an orderly and timely manner. The wound is stuck — ‘stalled’ — in the inflammatory phase, as indicated by a lack … Continue reading ›

  2. TREAT

    How to use Woulgan to reACTivate stalled wounds The evidence, the science and practical guidance How Woulgan reACTivates macrophages to treat stalled wounds How macrophages in stalled wounds can be activated by stimulation with SBG Woulgan – reACTivate stalled healing Evidence and case studies Bioactive SBG in clinical practice – case reviews and treatment plans … Continue reading ›